Advertisement
Screener

ACTINIUM PHARMACEUTICALS, INC. (ATNM) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ACTINIUM PHARMACEUTICALS, INC. Operating Cash Flow

ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Operating Cash Flow of -$11.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07

  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.18M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.87M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.29M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.33M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$24.58M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$33.07M.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$47.34M, a 647.61% decline from fiscal 2022.
  • ACTINIUM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $8.64M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 151 monthNet Cash Provided by (Used in) Operating Activities 154 monthNet Cash Provided by (Used in) Operating Activities 157 monthNet Cash Provided by (Used in) Operating Activities 160 monthNet Cash Provided by (Used in) Operating Activities 163 monthNet Cash Provided by (Used in) Operating Activities 166 month
2026-06-30-$5.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$11.05M
10-Q · filed 2026-08-07
-$16.34M
derived: sum of 3 quarters · filed 2026-08-07
-$22.66M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$5.87M
10-Q · filed 2026-05-08
-$11.16M
derived: sum of 2 quarters · filed 2026-05-08
-$17.48M
derived: sum of 3 quarters · filed 2026-05-08
-$22.88M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$5.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
-$11.61M
derived: sum of 2 quarters · filed 2026-03-30
-$17.01M
derived: sum of 3 quarters · filed 2026-08-07
-$24.58M
10-K · filed 2026-03-30
2025-09-30-$6.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$11.72M
derived: sum of 2 quarters · filed 2026-08-07
-$19.29M
10-Q · filed 2025-11-14
-$25.04M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$5.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$12.97M
10-Q · filed 2026-08-07
-$18.72M
derived: sum of 3 quarters · filed 2026-08-07
-$30.69M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$7.57M
10-Q · filed 2026-05-08
-$13.32M
derived: sum of 2 quarters · filed 2026-05-08
-$25.30M
derived: sum of 3 quarters · filed 2026-05-08
-$33.27M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$5.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
-$17.73M
derived: sum of 2 quarters · filed 2026-03-30
-$25.70M
derived: sum of 3 quarters · filed 2026-03-30
-$33.07M
10-K · filed 2026-03-30
2024-09-30-$11.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$19.95M
derived: sum of 2 quarters · filed 2025-11-14
-$27.32M
10-Q · filed 2025-11-14
-$34.81M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30-$7.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$15.35M
10-Q · filed 2025-08-08
-$22.84M
derived: sum of 3 quarters · filed 2025-08-08
-$33.96M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31-$7.37M
10-Q · filed 2025-05-09
-$14.86M
derived: sum of 2 quarters · filed 2025-05-09
-$25.99M
derived: sum of 3 quarters · filed 2025-05-09
-$39.63M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31-$7.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$18.61M
derived: sum of 2 quarters · filed 2025-03-31
-$32.26M
derived: sum of 3 quarters · filed 2025-03-31
-$47.34M
10-K · filed 2025-03-31
2023-09-30-$11.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$24.77M
derived: sum of 2 quarters · filed 2024-11-14
-$39.84M
10-Q · filed 2024-11-14
-$47.62M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$13.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
-$28.72M
10-Q · filed 2024-08-05
-$36.50M
derived: sum of 3 quarters · filed 2024-08-05
-$42.21M
derived: sum of 4 quarters · filed 2024-08-05
2023-03-31-$15.08M
10-Q · filed 2024-04-26
-$22.86M
derived: sum of 2 quarters · filed 2024-04-26
-$28.57M
derived: sum of 3 quarters · filed 2024-04-26
-$652.00K
derived: sum of 4 quarters · filed 2024-04-26
2022-12-31-$7.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$13.49M
derived: sum of 2 quarters · filed 2024-03-29
$14.43M
derived: sum of 3 quarters · filed 2024-03-29
$8.64M
10-K · filed 2024-03-29
2022-09-30-$5.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$22.20M
derived: sum of 2 quarters · filed 2023-11-02
$16.42M
10-Q · filed 2023-11-02
$11.37M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$27.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$22.14M
10-Q · filed 2023-08-14
$17.09M
derived: sum of 3 quarters · filed 2023-08-14
$11.50M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$5.78M
10-Q · filed 2023-05-15
-$10.83M
derived: sum of 2 quarters · filed 2023-05-15
-$16.42M
derived: sum of 3 quarters · filed 2023-05-15
-$21.00M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$5.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$10.64M
derived: sum of 2 quarters · filed 2023-03-31
-$15.22M
derived: sum of 3 quarters · filed 2023-03-31
-$20.87M
10-K · filed 2023-03-31
2021-09-30-$5.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$10.17M
derived: sum of 2 quarters · filed 2022-11-14
-$15.81M
10-Q · filed 2022-11-14
-$22.07M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$4.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$10.23M
10-Q · filed 2022-08-12
-$16.48M
derived: sum of 3 quarters · filed 2022-08-12
-$21.48M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$5.64M
10-Q · filed 2022-05-13
-$11.90M
derived: sum of 2 quarters · filed 2022-05-13
-$16.89M
derived: sum of 3 quarters · filed 2022-05-13
-$21.41M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$6.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
-$11.25M
derived: sum of 2 quarters · filed 2022-03-25
-$15.76M
derived: sum of 3 quarters · filed 2022-03-25
-$21.62M
10-K · filed 2022-03-25
2020-09-30-$4.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$9.51M
derived: sum of 2 quarters · filed 2021-11-12
-$15.36M
10-Q · filed 2021-11-12
-$20.37M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$4.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$10.37M
10-Q · filed 2021-07-30
-$15.38M
derived: sum of 3 quarters · filed 2021-07-30
-$20.97M
derived: sum of 4 quarters · filed 2021-07-30
2020-03-31-$5.85M
10-Q · filed 2021-05-14
-$10.87M
derived: sum of 2 quarters · filed 2021-05-14
-$16.46M
derived: sum of 3 quarters · filed 2021-05-14
-$21.83M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$5.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$10.61M
derived: sum of 2 quarters · filed 2021-03-31
-$15.97M
derived: sum of 3 quarters · filed 2021-03-31
-$21.46M
10-K · filed 2021-03-31
-$21.46M
10-K · filed 2020-05-08
2019-09-30-$5.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23
-$10.96M
derived: sum of 2 quarters · filed 2020-10-23
-$16.45M
10-Q · filed 2020-10-23
-$16.45M
10-Q · filed 2019-11-12
-$20.74M
derived: sum of 4 quarters · filed 2020-10-23
2019-06-30-$5.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
-$10.85M
10-Q · filed 2020-08-14
-$10.85M
10-Q · filed 2019-08-09
-$15.14M
derived: sum of 3 quarters · filed 2020-08-14
-$21.75M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$5.49M
10-Q · filed 2020-06-29
-$5.49M
10-Q · filed 2019-05-10
-$9.78M
derived: sum of 2 quarters · filed 2020-06-29
-$16.39M
derived: sum of 3 quarters · filed 2020-06-29
-$20.60M
derived: sum of 4 quarters · filed 2020-06-29
2018-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08
-$10.90M
derived: sum of 2 quarters · filed 2020-05-08
-$15.11M
derived: sum of 3 quarters · filed 2020-05-08
-$20.57M
10-K · filed 2020-05-08
2018-09-30-$6.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$10.82M
derived: sum of 2 quarters · filed 2019-11-12
-$16.28M
10-Q · filed 2019-11-12
-$19.45M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$4.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$9.67M
10-Q · filed 2019-08-09
-$12.84M
derived: sum of 3 quarters · filed 2019-08-09
-$18.71M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$5.46M
10-Q · filed 2019-05-10
-$8.63M
derived: sum of 2 quarters · filed 2019-05-10
-$14.50M
derived: sum of 3 quarters · filed 2019-05-10
-$21.64M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$9.04M
derived: sum of 2 quarters · filed 2019-03-15
-$16.18M
derived: sum of 3 quarters · filed 2019-03-15
-$21.55M
10-K · filed 2019-03-15
2017-09-30-$5.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$13.01M
derived: sum of 2 quarters · filed 2018-11-09
-$18.38M
10-Q · filed 2018-11-09
-$22.63M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$7.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$12.51M
10-Q · filed 2018-08-09
-$16.76M
derived: sum of 3 quarters · filed 2019-03-15
-$22.33M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31-$5.37M
10-Q · filed 2018-05-10
-$9.62M
derived: sum of 2 quarters · filed 2019-03-15
-$15.19M
derived: sum of 3 quarters · filed 2019-03-15
-$21.41M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$4.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$9.81M
derived: sum of 2 quarters · filed 2019-03-15
-$16.03M
derived: sum of 3 quarters · filed 2019-03-15
-$20.79M
10-K · filed 2019-03-15
2016-09-30-$5.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
-$11.79M
derived: sum of 2 quarters · filed 2017-11-03
-$16.55M
10-Q · filed 2017-11-03
-$20.51M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30-$6.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$10.98M
10-Q · filed 2017-08-04
-$14.94M
derived: sum of 3 quarters · filed 2018-03-16
-$18.44M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$4.76M
10-Q · filed 2017-05-15
-$8.72M
derived: sum of 2 quarters · filed 2018-03-16
-$12.22M
derived: sum of 3 quarters · filed 2018-03-16
-$17.49M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31-$3.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
-$7.46M
derived: sum of 2 quarters · filed 2018-03-16
-$12.73M
derived: sum of 3 quarters · filed 2018-03-16
-$18.54M
10-K · filed 2018-03-16
2015-09-30-$3.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
-$8.77M
derived: sum of 2 quarters · filed 2016-10-28
-$14.58M
10-Q · filed 2016-10-28
-$19.63M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$5.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
-$11.08M
10-Q · filed 2016-07-29
-$16.13M
derived: sum of 3 quarters · filed 2017-03-16
-$20.37M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$5.81M
10-Q · filed 2016-05-10
-$10.86M
derived: sum of 2 quarters · filed 2017-03-16
-$15.10M
derived: sum of 3 quarters · filed 2017-03-16
-$17.67M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31-$5.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$9.29M
derived: sum of 2 quarters · filed 2017-03-16
-$11.86M
derived: sum of 3 quarters · filed 2017-03-16
-$14.35M
10-K · filed 2017-03-16
2014-09-30-$4.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
-$6.81M
derived: sum of 2 quarters · filed 2015-10-30
-$9.30M
10-Q · filed 2015-10-30
-$10.65M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30-$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
-$5.06M
10-Q · filed 2015-08-07
-$6.41M
derived: sum of 3 quarters · filed 2016-03-11
-$8.03M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31-$2.49M
10-Q · filed 2015-05-08
-$3.84M
derived: sum of 2 quarters · filed 2016-03-11
-$5.46M
derived: sum of 3 quarters · filed 2016-03-11
-$6.47M
derived: sum of 4 quarters · filed 2016-03-11
-$53.19M
10-Q · filed 2014-05-12
2013-12-31-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
-$2.96M
derived: sum of 2 quarters · filed 2016-03-11
-$3.98M
derived: sum of 3 quarters · filed 2016-03-11
-$6.29M
10-K · filed 2016-03-11
-$50.70M
10-K · filed 2014-02-28
2013-09-30-$1.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
-$2.64M
derived: sum of 2 quarters · filed 2014-10-31
-$4.95M
10-Q · filed 2014-10-31
-$6.37M
derived: sum of 4 quarters · filed 2014-10-31
-$49.35M
10-Q · filed 2013-11-14
2013-06-30-$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
-$3.33M
10-Q · filed 2014-08-12
-$4.75M
derived: sum of 3 quarters · filed 2014-08-12
-$6.68M
derived: sum of 4 quarters · filed 2014-08-12
-$47.73M
10-Q · filed 2013-08-13
2013-03-31-$2.31M
10-Q · filed 2014-05-12
-$3.73M
derived: sum of 2 quarters · filed 2014-05-12
-$5.66M
derived: sum of 3 quarters · filed 2014-05-12
-$6.58M
derived: sum of 4 quarters · filed 2014-05-12
-$46.71M
10-Q · filed 2013-05-15
2012-12-31-$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
-$3.35M
derived: sum of 2 quarters · filed 2014-02-28
-$4.26M
derived: sum of 3 quarters · filed 2014-02-28
-$5.21M
10-K · filed 2014-02-28
-$44.40M
10-K · filed 2013-03-29
2012-09-30-$1.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$2.85M
derived: sum of 2 quarters · filed 2013-11-14
-$3.80M
10-Q · filed 2013-11-14
-$14.84K
10-Q · filed 2012-11-14
2012-06-30-$914.30K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
-$1.86M
10-Q · filed 2013-08-13
-$13.10K
10-Q/A · filed 2012-08-29
-$1.87M
derived: sum of 3 quarters · filed 2013-08-13
-$1.87M
derived: sum of 4 quarters · filed 2013-08-13
2012-03-31-$947.93K
10-Q · filed 2013-05-15
-$6.01K
10-Q · filed 2012-04-23
-$952.05K
derived: sum of 2 quarters · filed 2013-05-15
-$952.05K
derived: sum of 3 quarters · filed 2013-05-15
2011-12-31-$4.12K
10-Q · filed 2012-04-23
-$4.12K
derived: sum of 2 quarters · filed 2012-04-23
-$517.59K
10-K · filed 2013-03-29
$539.00
10-K · filed 2012-04-12
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14
$4.96K
10-Q · filed 2011-11-14
$4.96K
10-Q · filed 2012-11-14
2011-06-30$4.96K
10-Q/A · filed 2012-08-29
2010-12-31-$5.08K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12
-$18.26K
derived: sum of 2 quarters · filed 2012-04-12
$7.83K
10-K · filed 2012-04-12
2010-09-30-$13.18K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$12.91K
10-Q · filed 2011-11-14
2010-06-30$26.09K
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
BriaCell Therapeutics Corp. (BCTX)$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32